Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 23 of 23 entries
Sorted by: Best Match Show Resources per page
On the cardiac action of bis-diethyl amide of orthophthalic acid (neo-cardiamine).

Gazzetta sanitaria

CUGURRA F, CAVALLERI L.
PMID: 18143491
Gazz Sanit. 1949 Feb;20(2):66-71.

No abstract available.

Cite
CUGURRA F, CAVALLERI L. Sull'azione cardiaca della bis-dietil-amide dell'acido ortoftalico (neo-cardiamina). On the cardiac action of bis-diethyl amide of orthophthalic acid (neo-cardiamine). Gazz Sanit. 1949;20(2):66-71
CUGURRA, F., & CAVALLERI, L. (1949). Sull'azione cardiaca della bis-dietil-amide dell'acido ortoftalico (neo-cardiamina). On the cardiac action of bis-diethyl amide of orthophthalic acid (neo-cardiamine). Gazzetta sanitaria, 20(2), 66-71.
CUGURRA, F, and CAVALLERI, L. "Sull'azione cardiaca della bis-dietil-amide dell'acido ortoftalico (neo-cardiamina)." On the cardiac action of bis-diethyl amide of orthophthalic acid (neo-cardiamine). Gazzetta sanitaria vol. 20,2 (1949): 66-71.
CUGURRA F, CAVALLERI L. Sull'azione cardiaca della bis-dietil-amide dell'acido ortoftalico (neo-cardiamina). On the cardiac action of bis-diethyl amide of orthophthalic acid (neo-cardiamine). Gazz Sanit. 1949 Feb;20(2):66-71. Italian. PMID: 18143491.
Copy Download .nbib Format: NLM
[Cardiologic evaluation of patients undergoing chemotherapy].

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

Bordoni B, Urbinati S, Tosoni A, Labanti G, Brandes A.
PMID: 25845089
Monaldi Arch Chest Dis. 2014 Jun;82(2):68-74. doi: 10.4081/monaldi.2014.46.

Life expectancy in patients affected by cancer has recently increased because of early diagnosis and actual therapies. In recent years, Oncology and Cardiology developed a tight relationship because of common risk factors (i.e., obesity, smoking, alcool intake, etc...), and...

Cite
Bordoni B, Urbinati S, Tosoni A, et al. La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi Arch Chest Dis. 2014;82(2):68-74doi: 10.4081/monaldi.2014.46.
Bordoni, B., Urbinati, S., Tosoni, A., Labanti, G., & Brandes, A. (2014). La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 82(2), 68-74. https://doi.org/10.4081/monaldi.2014.46
Bordoni, Barbara, et al. "La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate." [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace vol. 82,2 (2014): 68-74. doi: https://doi.org/10.4081/monaldi.2014.46
Bordoni B, Urbinati S, Tosoni A, Labanti G, Brandes A. La consulenza cardiologica "mirata" nel paziente oncologico sottoposto a chemioterapia: come prevenire e monitorare la cardiotossicità in maniera appropriate. [Cardiologic evaluation of patients undergoing chemotherapy]. Monaldi Arch Chest Dis. 2014 Jun;82(2):68-74. doi: 10.4081/monaldi.2014.46. Italian. PMID: 25845089.
Copy Download .nbib Format: NLM
Cardiotoxicity of nano-particles.

Life sciences

Bostan HB, Rezaee R, Valokala MG, Tsarouhas K, Golokhvast K, Tsatsakis AM, Karimi G.
PMID: 27686832
Life Sci. 2016 Nov 15;165:91-99. doi: 10.1016/j.lfs.2016.09.017. Epub 2016 Sep 26.

Nano-particles (NPs) are used in industrial and biomedical fields such as cosmetics, food additives and biosensors. Beside their favorable properties, nanoparticles are responsible for toxic effects. Local adverse effects and/or systemic toxicity are described with nanoparticle delivery to target...

Cite
Bostan HB, Rezaee R, Valokala MG, et al. Cardiotoxicity of nano-particles. Life Sci. 2016;165:91-99doi: 10.1016/j.lfs.2016.09.017.
Bostan, H. B., Rezaee, R., Valokala, M. G., Tsarouhas, K., Golokhvast, K., Tsatsakis, A. M., & Karimi, G. (2016). Cardiotoxicity of nano-particles. Life sciences, 16591-99. https://doi.org/10.1016/j.lfs.2016.09.017
Bostan, Hasan Badie, et al. "Cardiotoxicity of nano-particles." Life sciences vol. 165 (2016): 91-99. doi: https://doi.org/10.1016/j.lfs.2016.09.017
Bostan HB, Rezaee R, Valokala MG, Tsarouhas K, Golokhvast K, Tsatsakis AM, Karimi G. Cardiotoxicity of nano-particles. Life Sci. 2016 Nov 15;165:91-99. doi: 10.1016/j.lfs.2016.09.017. Epub 2016 Sep 26. PMID: 27686832.
Copy Download .nbib Format: NLM
Assessment of Cardiotoxicity of Cancer Chemotherapy: The Value of Cardiac MR Imaging.

Magnetic resonance imaging clinics of North America

Ferreira de Souza T, Quinaglia T, Neilan TG, Coelho-Filho OR.
PMID: 31279455
Magn Reson Imaging Clin N Am. 2019 Aug;27(3):533-544. doi: 10.1016/j.mric.2019.04.001.

Chemotherapy is associated with cardiovascular injury, including the development of a cardiomyopathy and vascular remodeling. Cardiac magnetic resonance (CMR) is sensitive to detect not only established morphologic and functional abnormalities but also early, potentially reversible, signs of myocardial injury....

Cite
Ferreira de Souza T, Quinaglia T, Neilan TG, et al. Assessment of Cardiotoxicity of Cancer Chemotherapy: The Value of Cardiac MR Imaging. Magn Reson Imaging Clin N Am. 2019;27(3):533-544doi: 10.1016/j.mric.2019.04.001.
Ferreira de Souza, T., Quinaglia, T., Neilan, T. G., & Coelho-Filho, O. R. (2019). Assessment of Cardiotoxicity of Cancer Chemotherapy: The Value of Cardiac MR Imaging. Magnetic resonance imaging clinics of North America, 27(3), 533-544. https://doi.org/10.1016/j.mric.2019.04.001
Ferreira de Souza, Thiago, et al. "Assessment of Cardiotoxicity of Cancer Chemotherapy: The Value of Cardiac MR Imaging." Magnetic resonance imaging clinics of North America vol. 27,3 (2019): 533-544. doi: https://doi.org/10.1016/j.mric.2019.04.001
Ferreira de Souza T, Quinaglia T, Neilan TG, Coelho-Filho OR. Assessment of Cardiotoxicity of Cancer Chemotherapy: The Value of Cardiac MR Imaging. Magn Reson Imaging Clin N Am. 2019 Aug;27(3):533-544. doi: 10.1016/j.mric.2019.04.001. PMID: 31279455; PMCID: PMC6624085.
Copy Download .nbib Format: NLM
[Effect of Nerium oleander on electrocardiographic modifications].

Minerva medica

RAVERA M.
PMID: 14910354
Minerva Med. 1951 Oct 31;42(73):680-2.

No abstract available.

Cite
RAVERA M. Alterazioni elettrocardiografiche da Nerium oleander. [Effect of Nerium oleander on electrocardiographic modifications]. Minerva Med. 1951;42(73):680-2
RAVERA, M. (1951). Alterazioni elettrocardiografiche da Nerium oleander. [Effect of Nerium oleander on electrocardiographic modifications]. Minerva medica, 42(73), 680-2.
RAVERA, M. "Alterazioni elettrocardiografiche da Nerium oleander." [Effect of Nerium oleander on electrocardiographic modifications]. Minerva medica vol. 42,73 (1951): 680-2.
RAVERA M. Alterazioni elettrocardiografiche da Nerium oleander. [Effect of Nerium oleander on electrocardiographic modifications]. Minerva Med. 1951 Oct 31;42(73):680-2. Undetermined. PMID: 14910354.
Copy Download .nbib Format: NLM
Significance of variations in responses of five species of perfused hearts to common drugs.

Journal of the American Pharmaceutical Association. American Pharmaceutical Association

CRAVER BN, CAMERON A.
PMID: 14774298
J Am Pharm Assoc Am Pharm Assoc. 1950 Sep;39(9):509-12. doi: 10.1002/jps.3030390912.

No abstract available.

Cite
CRAVER BN, CAMERON A. Significance of variations in responses of five species of perfused hearts to common drugs. J Am Pharm Assoc Am Pharm Assoc. 1950;39(9):509-12doi: 10.1002/jps.3030390912.
CRAVER, B. N., & CAMERON, A. (1950). Significance of variations in responses of five species of perfused hearts to common drugs. Journal of the American Pharmaceutical Association. American Pharmaceutical Association, 39(9), 509-12. https://doi.org/10.1002/jps.3030390912
CRAVER, B N, and CAMERON, A. "Significance of variations in responses of five species of perfused hearts to common drugs." Journal of the American Pharmaceutical Association. American Pharmaceutical Association vol. 39,9 (1950): 509-12. doi: https://doi.org/10.1002/jps.3030390912
CRAVER BN, CAMERON A. Significance of variations in responses of five species of perfused hearts to common drugs. J Am Pharm Assoc Am Pharm Assoc. 1950 Sep;39(9):509-12. doi: 10.1002/jps.3030390912. PMID: 14774298.
Copy Download .nbib Format: NLM
Action of monoiodoacetic acid on cardiac activity; electrocardiographic research.

Bollettino della Societa italiana di biologia sperimentale

SARZANA G, BEVILOTTI V.
PMID: 18918729
Boll Soc Ital Biol Sper. 1947 May;23(5):494-7.

No abstract available.

Cite
SARZANA G, BEVILOTTI V. Azione dell'acido monoiodoacetico sull'attività cardiaca; ricerche elettrocardiografiche. Action of monoiodoacetic acid on cardiac activity; electrocardiographic research. Boll Soc Ital Biol Sper. 1947;23(5):494-7
SARZANA, G., & BEVILOTTI, V. (1947). Azione dell'acido monoiodoacetico sull'attività cardiaca; ricerche elettrocardiografiche. Action of monoiodoacetic acid on cardiac activity; electrocardiographic research. Bollettino della Societa italiana di biologia sperimentale, 23(5), 494-7.
SARZANA, G, and BEVILOTTI, V. "Azione dell'acido monoiodoacetico sull'attività cardiaca; ricerche elettrocardiografiche." Action of monoiodoacetic acid on cardiac activity; electrocardiographic research. Bollettino della Societa italiana di biologia sperimentale vol. 23,5 (1947): 494-7.
SARZANA G, BEVILOTTI V. Azione dell'acido monoiodoacetico sull'attività cardiaca; ricerche elettrocardiografiche. Action of monoiodoacetic acid on cardiac activity; electrocardiographic research. Boll Soc Ital Biol Sper. 1947 May;23(5):494-7. Italian. PMID: 18918729.
Copy Download .nbib Format: NLM
The influence of pneumodilator aerosols on respiratory distress of the serious heart.

Acta cardiologica

ANDRE MJ.
PMID: 18138221
Acta Cardiol. 1949;4(4):363-73.

No abstract available.

Cite
ANDRE MJ. De l'influence des aérosols pneumodilatateurs sur la détresse respiratoire du cardiaque grave. The influence of pneumodilator aerosols on respiratory distress of the serious heart. Acta Cardiol. 1949;4(4):363-73
ANDRE, M. J. (1949). De l'influence des aérosols pneumodilatateurs sur la détresse respiratoire du cardiaque grave. The influence of pneumodilator aerosols on respiratory distress of the serious heart. Acta cardiologica, 4(4), 363-73.
ANDRE, M J. "De l'influence des aérosols pneumodilatateurs sur la détresse respiratoire du cardiaque grave." The influence of pneumodilator aerosols on respiratory distress of the serious heart. Acta cardiologica vol. 4,4 (1949): 363-73.
ANDRE MJ. De l'influence des aérosols pneumodilatateurs sur la détresse respiratoire du cardiaque grave. The influence of pneumodilator aerosols on respiratory distress of the serious heart. Acta Cardiol. 1949;4(4):363-73. French. PMID: 18138221.
Copy Download .nbib Format: NLM
Further Experimental Justification For the Combination Therapy Strophanthin-Caffeine.

Helvetica medica acta

BISCHOFF L.
PMID: 21009934
Helv Med Acta. 1945 Jul;12:515-8.

No abstract available.

Cite
BISCHOFF L. Weitere experimentelle Begrundung der Kombinations-therapie Strophanthin-Koffein. Further Experimental Justification For the Combination Therapy Strophanthin-Caffeine. Helv Med Acta. 1945;12:515-8
BISCHOFF, L. (1945). Weitere experimentelle Begrundung der Kombinations-therapie Strophanthin-Koffein. Further Experimental Justification For the Combination Therapy Strophanthin-Caffeine. Helvetica medica acta, 12515-8.
BISCHOFF, L. "Weitere experimentelle Begrundung der Kombinations-therapie Strophanthin-Koffein." Further Experimental Justification For the Combination Therapy Strophanthin-Caffeine. Helvetica medica acta vol. 12 (1945): 515-8.
BISCHOFF L. Weitere experimentelle Begrundung der Kombinations-therapie Strophanthin-Koffein. Further Experimental Justification For the Combination Therapy Strophanthin-Caffeine. Helv Med Acta. 1945 Jul;12:515-8. German. PMID: 21009934.
Copy Download .nbib Format: NLM
Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida.

Archivos del Instituto de Cardiologia de Mexico

GUERRA F.
PMID: 21011766
Arch Inst Cardiol Mex. 1945;15(4):366-73.

No abstract available.

Cite
GUERRA F. Trabajo del corazón aislado bajo la acción de la ouabaina, digitalina, digilánidos, escilarina, nucleósidos, adrenalina, efedrina, metrazol y niketamida. Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida. Arch Inst Cardiol Mex. 1945;15(4):366-73
GUERRA, F. (1945). Trabajo del corazón aislado bajo la acción de la ouabaina, digitalina, digilánidos, escilarina, nucleósidos, adrenalina, efedrina, metrazol y niketamida. Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida. Archivos del Instituto de Cardiologia de Mexico, 15(4), 366-73.
GUERRA, F. "Trabajo del corazón aislado bajo la acción de la ouabaina, digitalina, digilánidos, escilarina, nucleósidos, adrenalina, efedrina, metrazol y niketamida." Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida. Archivos del Instituto de Cardiologia de Mexico vol. 15,4 (1945): 366-73.
GUERRA F. Trabajo del corazón aislado bajo la acción de la ouabaina, digitalina, digilánidos, escilarina, nucleósidos, adrenalina, efedrina, metrazol y niketamida. Isolated heart work under the action of ouabain, digitalin, digilánnidos, escilarina, nucleosides, adrenaline, ephedrine, metrazol and niketamida. Arch Inst Cardiol Mex. 1945;15(4):366-73. Spanish. PMID: 21011766.
Copy Download .nbib Format: NLM
Cardiac side effects of targeted therapies.

Seminars in oncology nursing

Shank Coviello J.
PMID: 25085029
Semin Oncol Nurs. 2014 Aug;30(3):175-82. doi: 10.1016/j.soncn.2014.05.005.

OBJECTIVES: To review common cardiac side effects, their clinical presentation, and recommendations for assessment and management of patients receiving molecularly targeted cancer therapies.DATA SOURCES: Peer-reviewed literature.CONCLUSION: Although there is no established guideline for pretreatment cardiac evaluation and monitoring of...

Cite
Shank Coviello J. Cardiac side effects of targeted therapies. Semin Oncol Nurs. 2014;30(3):175-82doi: 10.1016/j.soncn.2014.05.005.
Shank Coviello, J. (2014). Cardiac side effects of targeted therapies. Seminars in oncology nursing, 30(3), 175-82. https://doi.org/10.1016/j.soncn.2014.05.005
Shank Coviello, Jessica. "Cardiac side effects of targeted therapies." Seminars in oncology nursing vol. 30,3 (2014): 175-82. doi: https://doi.org/10.1016/j.soncn.2014.05.005
Shank Coviello J. Cardiac side effects of targeted therapies. Semin Oncol Nurs. 2014 Aug;30(3):175-82. doi: 10.1016/j.soncn.2014.05.005. PMID: 25085029.
Copy Download .nbib Format: NLM
Showing 13 to 23 of 23 entries